Health
Study Sees Survival Boost For BRCA1/2 Carriers Tested Before Breast Cancer Diagnosis – Precision Oncology News
The analysis suggested survival and other benefits for breast cancer patients with BRCA1/2 mutations who were aware of their germline risk before diagnosis.
NEW YORK Women carrying pathogenic germline BRCA1/2 variants who develop breast cancer appear to fare better if their germline risk variants were uncovered prior to their cancer diagnosis, even if they do not undergo preventative procedures such as risk-reduction surgery, according to new research from Israel.
-
Noosa News19 hours agoPhotographer Nadia Shevtsova remembered by family in touching tribute after deadly crash at Gold Coast
-
General10 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General13 hours agoMajority of Australia’s first Ashes Test squad to feature in Sheffield Shield round four
-
Noosa News21 hours agoWoman’s lucky escape after car rolls and crashes onto tracks before being hit by oncoming train in Kingston, Logan